Discontinued ProductUnfortunately 4-Aminobutylphosphonic acid (Cat. No. 0265) has been withdrawn from sale for commercial reasons.
GABAB receptor ligand.
|Storage||Store at RT|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Preparing Stock Solutions
The following data is based on the product molecular weight 153.12. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||6.53 mL||32.65 mL||65.31 mL|
|5 mM||1.31 mL||6.53 mL||13.06 mL|
|10 mM||0.65 mL||3.27 mL||6.53 mL|
|50 mM||0.13 mL||0.65 mL||1.31 mL|
References are publications that support the products' biological activity.
View Related Products by Target
View Related Products by Product Action
Keywords: 4-Aminobutylphosphonic acid, supplier, GABAB, Receptors, GABAB, Receptors, Tocris Bioscience
Citations for 4-Aminobutylphosphonic acid
Citations are publications that use Tocris products.
Currently there are no citations for 4-Aminobutylphosphonic acid.
Reviews for 4-Aminobutylphosphonic acid
There are currently no reviews for this product. Be the first to review 4-Aminobutylphosphonic acid and earn rewards!
Have you used 4-Aminobutylphosphonic acid?
Submit a review and receive an Amazon gift card.
$10US/$10CAN/€7/£6 gift card for a review without an image
$25US/$25CAN/€18/£15 gift card for a review with an image
*Offer only valid in the USA / Canada, UK and EuropeSubmit a Review
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
GABA Receptors Scientific Review
Written by Ian Martin, Norman Bowery and Susan Dunn, this review provides a history of the GABA receptor, as well as discussing the structure and function of the various subtypes and the clinical potential of receptor modulators; compounds available from Tocris are listed.
The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.
Schizophrenia is a debilitating psychiatric disorder that affects 1% of the worldwide population. This poster describes the neurobiology of Schizophrenia, as well as highlighting the genetic and environmental factors that play a fundamental role in the etiology of the disease. The current and emerging drug targets are also discussed.